anmelden
Analysen von Richard Vosser
| 07.02.24 | Bayer Neutral | JP Morgan Chase & Co. | |
| 07.02.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 06.02.24 | Merck Overweight | JP Morgan Chase & Co. | |
| 05.02.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.02.24 | Bayer Neutral | JP Morgan Chase & Co. | |
| 01.02.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 01.02.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 01.02.24 | Merck Overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 31.01.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 29.01.24 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 26.01.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 26.01.24 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 24.01.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 23.01.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 19.01.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 15.01.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 12.01.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 12.01.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 12.01.24 | Bayer Neutral | JP Morgan Chase & Co. | |
| 11.01.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 11.01.24 | Merck Overweight | JP Morgan Chase & Co. | |
| 09.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 09.01.24 | Merck Overweight | JP Morgan Chase & Co. | |
| 08.01.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 08.01.24 | Bayer Neutral | JP Morgan Chase & Co. | |
| 08.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 03.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 03.01.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 02.01.24 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 02.01.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 02.01.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 11.12.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 07.12.23 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 05.12.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 05.12.23 | MorphoSys Overweight | JP Morgan Chase & Co. | |
| 05.12.23 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 05.12.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.12.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 05.12.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 05.12.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.12.23 | Merck Overweight | JP Morgan Chase & Co. | |
| 05.12.23 | Bayer Neutral | JP Morgan Chase & Co. | |
| 05.12.23 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 30.11.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 27.11.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 20.11.23 | Bayer Neutral | JP Morgan Chase & Co. | |
| 12.11.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 09.11.23 | Merck Overweight | JP Morgan Chase & Co. | |
| 08.11.23 | Bayer Neutral | JP Morgan Chase & Co. | |
| 06.11.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
